Mitragynine, the main active compound in kratom, has a half-life that ranges roughly from 7 to 24 hours in humans, depending on which study you look at and how the measurement was taken. That wide spread is not a typo or a sign of bad science; it reflects genuine differences in study design, kratom formulation, and individual biology. The range matters because it determines how long kratom’s effects linger, how long the compound remains detectable, and how it interacts with other substances your liver is trying to process at the same time.
Why the Half-Life Estimates Vary So Much
The first formal pharmacokinetic study of mitragynine in humans, conducted with nine subjects given a single oral dose, reported a terminal half-life of about 23 hours, though with a large standard deviation of roughly 16 hours, meaning individual results ranged widely.1PubMed Central. Pharmacokinetics of mitragynine in man A later study in healthy volunteers found a shorter half-life for mitragynine of about 9 hours, and a similar half-life for 7-hydroxymitragynine of about 7 hours.2ACS Pharmacology & Translational Science. Effects of Itraconazole on Pharmacokinetics of Mitragynine and 7‑Hydroxymitragynine in Healthy Volunteers A systematic review pooling data from both animal and human studies placed the half-life at 3 to 9 hours.3PubMed Central. Pharmacokinetics of mitragynine, a major analgesic alkaloid in kratom (Mitragyna speciosa): A systematic review
A few things explain the discrepancy. First, terminal half-life measurements are sensitive to how long researchers track the drug in blood. If you sample blood for a long enough period, you pick up a slow tail-end of elimination that shorter sampling windows miss. Second, the early nine-subject study had enormous individual variability, which is a common pattern with kratom because the liver enzymes that break it down vary considerably from person to person. Third, different kratom products contain different concentrations of alkaloids, and concentrated extracts behave differently than dried leaf powder. For practical purposes, a reasonable working estimate for most people taking standard kratom products is a half-life somewhere in the range of 7 to 23 hours, with the majority of data clustering toward the shorter end of that window.
How Your Body Breaks Down Kratom
Mitragynine is absorbed quickly after you swallow it. Plasma levels peak in under an hour on average, which lines up with the rapid onset of effects that kratom users typically describe.1PubMed Central. Pharmacokinetics of mitragynine in man Once in the bloodstream, mitragynine spreads widely through body tissues. That large volume of distribution is part of why the compound takes a while to fully clear; it is not just floating around in blood waiting to be filtered out, it is stored throughout the body and slowly released back into circulation.
The liver does the heavy lifting when it comes to metabolizing mitragynine. The primary enzyme responsible is CYP3A4, with smaller contributions from CYP2D6 and CYP2C9.4PubMed. Metabolite profiling and identification of enzymes responsible for the metabolism of mitragynine, the major alkaloid of Mitragyna speciosa (kratom) CYP3A4 is the same enzyme that processes a huge proportion of commonly used medications, from certain antibiotics and antifungals to blood pressure drugs and sedatives. This overlap becomes important when we get to drug interactions.
One of the most significant things CYP3A4 does to mitragynine is convert it into 7-hydroxymitragynine, a metabolite that is a much more potent activator of opioid receptors in the brain.5PubMed Central. 7-Hydroxymitragynine Is an Active Metabolite of Mitragynine and a Key Mediator of Its Analgesic Effects While 7-hydroxymitragynine exists in the kratom leaf itself in tiny amounts, the body produces it in much larger quantities from the mitragynine it absorbs. Research in both mouse and human liver preparations has confirmed that brain levels of this metabolite are high enough to account for most of the painkilling effect people experience from kratom.5PubMed Central. 7-Hydroxymitragynine Is an Active Metabolite of Mitragynine and a Key Mediator of Its Analgesic Effects A human volunteer study confirmed this metabolic conversion happens efficiently in people, with 7-hydroxymitragynine appearing in blood as early as 15 minutes after dosing.6PubMed Central. Effects of Itraconazole on Pharmacokinetics of Mitragynine and 7-Hydroxymitragynine in Healthy Volunteers
The practical takeaway is that when you take kratom, your body is not just processing one compound. It is managing mitragynine itself, producing a more potent metabolite (7-hydroxymitragynine), and generating a handful of other breakdown products. The most abundant metabolite found in urine is 9-O-demethylmitragynine, which is produced by multiple liver enzymes including CYP2C19, CYP3A4, and CYP2D6.7Journal of Analytical Toxicology. CYP450-Mediated Metabolism of Mitragynine and Investigation of Metabolites in Human Urine The overall elimination picture is not just about mitragynine’s half-life; it is about how long all of these active and inactive metabolites stick around.
How Long Effects Last Compared to How Long It Stays in Your System
Users commonly report that kratom’s noticeable effects last roughly 4 to 6 hours, depending on dose and tolerance. But mitragynine and its metabolites remain detectable in your body for much longer than that. A drug’s half-life tells you how long it takes for half of the compound to be eliminated, but it typically takes about five half-lives for a substance to be functionally cleared. Using the more conservative half-life estimate of around 23 hours, that would mean about five days before mitragynine drops to negligible blood levels in some individuals. Using the shorter estimates of 7 to 9 hours, clearance would happen within roughly two days.
The reason effects wear off before the drug is fully gone comes down to how much of the compound needs to be in your brain to produce a noticeable effect. Once blood levels drop below a certain threshold, you stop feeling the drug even though it is still measurable in plasma. The active metabolite 7-hydroxymitragynine has its own half-life of about 7 hours, which more closely tracks with the typical duration of subjective effects.2ACS Pharmacology & Translational Science. Effects of Itraconazole on Pharmacokinetics of Mitragynine and 7‑Hydroxymitragynine in Healthy Volunteers
Regular users also accumulate mitragynine over days of repeated dosing. A study tracking multiple daily doses of kratom extract found that steady-state plasma levels, the point at which intake and elimination balance out, took 7 to 9 days to reach for both mitragynine and 7-hydroxymitragynine.8Journal of Analytical Toxicology. Mitragynine and 7-hydroxy-mitragyine plasma pharmacokinetics in humans after single and 15 multiple oral kratom extract doses That means if you use kratom daily, it builds up in your system over about a week before leveling off. Stopping after regular use would therefore mean a longer total clearance time than stopping after a single dose.
What Changes How Long Kratom Stays
Several factors can shift the timeline in either direction. Because CYP3A4 is the primary enzyme responsible for clearing mitragynine, anything that slows down or speeds up CYP3A4 activity directly changes how long kratom lingers.
People who take medications that inhibit CYP3A4 should pay particular attention. In a rat study, ketoconazole, a strong CYP3A4 inhibitor, increased total exposure to mitragynine by about 120% and exposure to 7-hydroxymitragynine by about 130%.9The Journal of Pharmacology and Experimental Therapeutics. Behavioral Pharmacology Pharmacokinetic and Pharmacodynamic Consequences of Cytochrome P450 3A Inhibition on Mitragynine Metabolism in Rats A human clinical study with itraconazole, another CYP3A4 inhibitor, supported the idea that kratom’s metabolism is primarily blocked in the gut rather than the liver, but the net effect was still a meaningful increase in kratom alkaloid levels.10PubMed Central. Clinical Assessment of the Drug Interaction Potential of the Psychotropic Natural Product Kratom Common medications that inhibit CYP3A4 include certain antifungals, some antibiotics like clarithromycin, HIV protease inhibitors, and even grapefruit juice. Taking any of these alongside kratom can effectively extend how long kratom stays active and raise peak levels.
Mitragynine itself also inhibits liver enzymes, creating a feedback loop that matters for people combining kratom with other drugs. Research using human liver preparations showed that mitragynine is a strong competitive inhibitor of CYP2D6 and can also inhibit CYP3A4 in a time-dependent way, meaning the inhibition gets worse with continued exposure.11PubMed Central. Refined Prediction of Pharmacokinetic Kratom-Drug Interactions: Time-Dependent Inhibition Considerations Modeling predicted that a single 2-gram kratom dose could increase blood levels of the sedative midazolam by nearly sixfold.11PubMed Central. Refined Prediction of Pharmacokinetic Kratom-Drug Interactions: Time-Dependent Inhibition Considerations That is a clinically serious interaction. Whole kratom extracts showed even stronger enzyme inhibition than pure mitragynine alone, suggesting that other alkaloids in the leaf contribute to the effect.12Scientific Reports. Chemical composition and biological effects of kratom (Mitragyna speciosa): In vitro studies with implications for efficacy and drug interactions
Genetic variation in CYP enzymes also plays a role. People who are naturally slow metabolizers of CYP3A4 or CYP2D6, a trait that varies by ethnicity and individual genetics, will clear kratom more slowly and experience higher peak levels from the same dose. This is hard to predict without pharmacogenetic testing, but it helps explain why two people taking identical doses can have starkly different experiences with duration and intensity.
Does Kratom Show Up on Drug Tests
Standard workplace and clinical drug screens do not test for kratom alkaloids. A case study confirmed that standard immunoassays came back negative across the board for amphetamines, barbiturates, benzodiazepines, opiates, methadone, THC, and other common targets in a person who was actively using kratom.13PubMed. Kratom alkaloids and O-desmethyltramadol in urine of a “Krypton” herbal mixture consumer Despite mitragynine’s activity at opioid receptors, its chemical structure is different enough from classical opioids that it does not trip the antibody-based reagents used in standard panels.
There is one documented exception worth knowing about. A kratom metabolite has been shown to trigger false positive results on certain immunoassay tests for methadone metabolites.14American Journal of Clinical Pathology. A Kratom Metabolite Causes False Positive Urine Drug Screening Results for Methadone If you use kratom and are being screened in a clinical setting that tests for methadone, this could create confusion. Confirmatory testing using mass spectrometry would resolve the issue, but not every clinic follows up immediately.
When labs specifically want to detect kratom, they use specialized liquid chromatography-mass spectrometry methods. Even these methods have their challenges. One study found that a routine high-resolution mass spectrometry screening could not distinguish mitragynine from two of its closely related compounds, speciogynine and speciociliatine, without additional method refinement.15PubMed Central. Drug testing for mitragynine and kratom: Analytical challenges and medico-legal considerations In urine, kratom metabolites are generally detectable for several days after use. In blood, the detection window is shorter and depends on the half-life dynamics described earlier.
Hair testing for kratom is possible and has been used in forensic settings to assess long-term or chronic use. As with other drugs, hair analysis reveals a pattern of use over weeks to months rather than pinpointing a single dose. Researchers have validated methods for detecting mitragynine and 7-hydroxymitragynine in hair, though very recent or infrequent use is hard to pick up because the drug needs time to be incorporated into the growing hair shaft.16Journal of Analytical Toxicology. LC–MS-MS method for mitragynine and 7-hydroxymitragynine in hair and its application in authentic hair samples of suspected kratom abusers
How Product Type Affects Clearance Time
Not all kratom products deliver the same pharmacokinetic profile. Concentrated commercial extracts produce higher blood levels of mitragynine and 7-hydroxymitragynine per milligram of alkaloid compared to traditional dried leaf preparations. A study in rats found that four key alkaloids, including mitragynine and 7-hydroxymitragynine, showed 1.6 to 2.4 times higher dose-adjusted systemic exposure when given as a commercial liquid extract compared to traditional kratom tea.17Journal of Natural Products. Pharmacokinetics of Eleven Kratom Alkaloids Following an Oral Dose of Either Traditional or Commercial Kratom Products in Rats
Human data echoed this finding. A pharmacokinetic study comparing a concentrated kratom extract to earlier data from dried leaf powder found that peak blood levels of mitragynine were higher with the extract, even at similar or slightly lower alkaloid doses. At the highest dose tested, total drug exposure was 40 to 70 percent higher from the extract despite only a 10 percent increase in the actual milligrams of mitragynine administered.8Journal of Analytical Toxicology. Mitragynine and 7-hydroxy-mitragyine plasma pharmacokinetics in humans after single and 15 multiple oral kratom extract doses Higher peak levels and greater total exposure mean the body has more compound to clear, which stretches out the effective duration even if the half-life itself does not change.
The formulation also affects which minor alkaloids reach systemic circulation. Beyond mitragynine and 7-hydroxymitragynine, kratom contains dozens of other alkaloids. Most of these clear very quickly. Paynantheine and speciogynine, for instance, were only detectable for about an hour after dosing in rats.17Journal of Natural Products. Pharmacokinetics of Eleven Kratom Alkaloids Following an Oral Dose of Either Traditional or Commercial Kratom Products in Rats Only four of the eleven alkaloids tracked in that study, mitragynine, 7-hydroxymitragynine, speciociliatine, and corynantheidine, were still present in blood eight hours after dosing. This means the complex cocktail of alkaloids that defines the full kratom experience narrows to a handful of longer-lasting compounds within a few hours.
Blood Sample Stability and Forensic Timing
An underappreciated wrinkle in the “how long does kratom stay” question comes from the forensic and clinical side: mitragynine is not particularly stable in stored blood samples. A study comparing common blood collection tubes found that mitragynine concentrations in blood dropped measurably within one to two weeks depending on the type of tube used. The most commonly used preservative tube, sodium fluoride/potassium oxalate, kept mitragynine stable for about a week before significant degradation began.18Chula Digital Collections. Comparison of mitragynine stability in human blood in common blood collection tubes Other tube types showed the concentration dropping even earlier, between one and seven days.
This matters in situations where blood is drawn and then stored before analysis, such as autopsy cases, DUI investigations, or clinical toxicology workups. If the sample sits too long before being tested, the measured mitragynine level will underrepresent what was actually in the person’s blood at the time of collection. For anyone involved in forensic or legal proceedings where kratom use is relevant, the timing between sample collection and laboratory analysis is more than a procedural detail.